Solid Tumours

• CLINICAL_TRIALS trial_result · 2022-01-11
  Clinical Trial Update: A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours [Phase 3]

  A Phase 3 bioequivalence study of docetaxel injection in patients with solid tumours has completed.

• CLINICAL_TRIALS trial_result · 2020-08-12
  Clinical Trial Update: Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors [Phase 2]

  A Phase II pediatric trial of pazopanib sponsored by Novartis under the Children's Oncology Group has completed with posted results.

• CLINICAL_TRIALS trial_result · 2019-09-13
  Clinical Trial Update: Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment [Phase 1]

  Phase 1 trial evaluating blood levels and safety of olaparib in patients with advanced solid tumours and varying liver function (completed; …

• CLINICAL_TRIALS trial_result · 2019-03-25
  Clinical Trial Update: Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours [Phase 1]

  Phase Ib study of AZD1775 with carboplatin and paclitaxel in adult Asian patients with solid tumours has completed; results posted in 2019.

• CLINICAL_TRIALS trial_result · 2018-09-13
  Clinical Trial Update: The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour. [Phase 1]

  Phase 1 study assessing pharmacokinetics and safety of olaparib alone and with paclitaxel in Chinese patients with advanced solid tumours.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-06-30
  Clinical Trial Update: Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers [Phase 1]

  Phase 1 ADME study evaluating single-dose [14C] Selumetinib in volunteers has completed.